Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Laurantis Pharma logo — Advancing specialty pharmaceutical innovation with first-in-...

Laurantis Pharma

Advancing specialty pharmaceutical innovation with first-in-class products in dermatology, ophthalmology, and oncology.

Founded 2003 2-10 employees Venture round Total: $5.64M Biotechnology, Health and Wellness +1

General Information

Company Name Laurantis Pharma
Founded Year 2003
Employees 2-10
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Laurantis Pharma. To contact Laurantis Pharma, visit laurantis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Laurantis Pharma compare?

A PDF of Laurantis Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Laurantis Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Laurantis Pharma

Laurantis Pharma is a specialized pharmaceutical development company with a diverse, clinical-stage portfolio spanning three key therapeutic areas: dermatology, ophthalmology, and oncology. Leveraging two proprietary technologies, the company is creating pioneering products for important niche indications in these fields. Established in December 2010 through the merger of Finnish drug development firms Oy Lx Therapies Ltd and BioCis Pharma Oy. With a founding year of 2003, Laurantis Pharma operates in the Biotechnology and Pharmaceutical industries. The most recent funding was a €5.64M Venture Round investment at 04 September 2012, led by Broadview Ventures and Inveni Capital. Laurantis Pharma aims to advance specialty pharmaceutical innovation with first-in-class products in dermatology, ophthalmology, and oncology, as depicted in its slogan.

Business keywords: specialty pharmaceuticals, clinical-stage portfolio, dermatology, ophthalmology, oncology, proprietary technologies, drug development, niche indications, Finnish pharmaceutical industry, mergers and acquisitions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €5.64M 2
Broadview Ventures Inveni Capital
Broadview Ventures, Inveni Capital
04 Sep 2012

Laurantis Pharma Alternatives & Competitors

View All Alternatives
Laurantis Pharma vs
AiViva Biopharma, Inc.
AiViva Biopharma, Inc. United States

Developing Novel, Localized Treatments in Oncology, Ophthalmology, Dermatology, and Urology to Trans...

16 employees
Biotechnology, Pharmaceutical
Laurantis Pharma vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care
Laurantis Pharma vs
IXALTIS SA
IXALTIS SA France

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

Venture round
2 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Laurantis Pharma

Advancing specialty pharmaceutical innovation with first-in-class products in dermatology, ophthalmology, and oncology.
Laurantis Pharma was founded in 2003.
Laurantis Pharma operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on specialty pharmaceuticals, clinical-stage portfolio, dermatology and ophthalmology.
Laurantis Pharma has approximately 2-10 employees.
Laurantis Pharma has completed 1 funding round, raising a total of $5.64M. The latest funding stage is Venture round.
Top alternatives and competitors to Laurantis Pharma include AiViva Biopharma, Inc., Archimedes Pharma, IXALTIS SA, Centessa Pharmaceuticals, Biodexa Pharmaceuticals PLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Laurantis Pharma and AiViva Biopharma, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Laurantis Pharma, https://bouncewatch.com/company/laurantis-pharma, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes